DEFA14A: Lifeway Foods Faces Board Challenge Despite Record Earnings

Lifeway Foods announces it will review a director nomination notice from Edward Smolyansky to replace the entire board, despite reporting record full-year earnings for 2024 and a 22nd consecutive quarter of growth.

Summary

• Lifeway Foods, Inc. has received a director nomination notice from Edward Smolyansky proposing seven candidates to replace the entire Board of Directors at the 2025 annual meeting of shareholders.
• The company's Audit and Corporate Governance Committee will review the nominees, and the Board will make a recommendation in due course.
• Lifeway emphasizes its recent record full-year earnings for 2024 and its 22nd consecutive quarter of growth.
• The company states that Edward Smolyansky was previously terminated for cause as an officer of the Company.
• Lifeway assures shareholders that they do not need to take any action at this time.
• The company intends to file a proxy statement on Schedule 14A with the SEC in connection with the solicitation of proxies for the 2025 annual meeting.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to the record earnings and growth, but tempered by the uncertainty of the proxy contest and the potential for disruption.

Positives

• Lifeway Foods reported record full-year earnings for 2024.
• The company achieved its 22nd consecutive quarter of growth.
• Lifeway maintains a consistent dialogue with its shareholders and welcomes constructive input.

Negatives

• Lifeway Foods is facing a potential proxy contest with a nomination notice to replace the entire board.
• Edward Smolyansky, the nominator, was previously terminated for cause as an officer of the company.

Risks

• The company faces a potential proxy contest, which could be distracting and have adverse effects on the business.
• There is uncertainty regarding proposals or other actions taken by shareholders related to the unsolicited proposal made by Danone North America PBC (Danone) to acquire all of the shares of Lifeway's stock that Danone does not already own.
• The company's future performance is subject to risks and uncertainties, including price competition, customer decisions, competitor actions, changes in commodity pricing, government regulation, and delays in new product introductions.

Future Outlook

Lifeway believes its business will continue to grow as consumers focus on the importance of a healthy microbiome and the gut-brain connection.

Management Comments

• Lifeway maintains a consistent dialogue with its shareholders and welcomes constructive input on creating shareholder value.
• Lifeway's leadership and Board are proud of the incredible growth the brand has achieved.
• Our primary focus is on Lifeway's opportunities and momentum.
• We look forward to providing updates as we continue to execute on behalf of all shareholders.

Industry Context

The announcement comes as the probiotic and fermented foods market is experiencing growth, driven by increasing consumer awareness of gut health and the microbiome.

Comparison to Industry Standards

• It is difficult to compare Lifeway directly to industry standards without specific financial details and competitor data.
• However, the company's 22 consecutive quarters of growth suggest a strong competitive position within the Kefir and fermented probiotic products market.
• Companies like Danone (through its yogurt brands) and Chobani (which has also entered the probiotic space) are potential competitors, but their overall business models are broader than Lifeway's.

Stakeholder Impact

• Shareholders face uncertainty due to the potential proxy contest.
• Employees may experience anxiety related to potential changes in leadership.
• Customers may be unaffected in the short term, but long-term strategic shifts could impact product offerings.
• Suppliers and creditors may experience uncertainty depending on the outcome of the proxy contest.

Next Steps

• Lifeway's Audit and Corporate Governance Committee will review Mr. Smolyansky's nominees.
• The Board will make a recommendation in due course.
• The Company intends to file a proxy statement on Schedule 14A with the SEC.
• Lifeway will continue to execute on behalf of all shareholders.

Key Dates

Keywords

Lifeway Foods, Director Nomination, Proxy Contest, Board of Directors, Edward Smolyansky, Earnings, Kefir, Shareholders, Governance